Optimization of an Elispot assay to detect cytomegalovirus-specific CD8 + T lymphocytes

Human Immunology

Volumn 65, Issue 11, 2004, Pages 1307-1318

  Godard, Brigitte ^a   Gazagne, Agnès ^a,b   Gey, Alain ^a,b   Baptiste, Muriel ^a   Vingert, Benoit ^b   Pegaz Fiornet, Beatrice ^a   Strompf, Laurence ^a   Fridman, Wolf H ^a,b   Glotz, Denis ^a   Tartour, Eric ^a,b  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b INSERM   (France)

Author keywords

cellular immunity; cytomegalovirus; Elispot; specific CD8 + T cells; transplantation

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; GRANZYME B; HLA A2 ANTIGEN; HLA B7 ANTIGEN; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ACCURACY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LYMPHOCYTE CULTURE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RELIABILITY; T LYMPHOCYTE SUBPOPULATION;

ANTIGEN-PRESENTING CELLS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTOMEGALOVIRUS INFECTIONS; GRANZYMES; HLA-A2 ANTIGEN; HUMANS; IMMUNOENZYME TECHNIQUES; INTERFERON TYPE II; INTERLEUKIN-2; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PEPTIDE FRAGMENTS; SERINE ENDOPEPTIDASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 8844238402     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2004.06.006     Document Type: Article

References (63)

1. M. Boeckh, W. Leisenring, S.R. Riddell, R.A. Bowden, M.L. Huang, D. Myerson, T. Stevens-Ayers, M.E. Flowers, T. Cunningham, L. Corey Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants importance of viral load and T-cell immunity Blood 101 2003 407
2. E.F. de Maar, E.A. Verschuuren, J.J. Homan vd Heide, D.M. Kas-Deelen, D. Jagernath, T.H. The, R.J. Ploeg, W.J. van Son Effects of changing immunosuppressive regimen on the incidence, duration, and viral load of cytomegalovirus infection in renal transplantation a single center report Transpl Infect Dis 4 2002 17
3. C.V. Paya, R.H. Wiesner, P.E. Hermans, J.J. Larson-Keller, D.M. Ilstrup, R.A. Krom, S. Rettke, T.F. Smith Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation a prospective multivariate time-dependent analysis J Hepatol 18 1993 185
4. M. Boeckh, R.A. Bowden, T. Gooley, D. Myerson, L. Corey Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients Blood 93 1999 1781
5. H. Einsele, H. Hebart, C. Kauffmann-Schneider, C. Sinzger, G. Jahn, P. Bader, T. Klingebiel, K. Dietz, J. Loffler, C. Bokemeyer, C.A. Muller, L. Kanz Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection Bone Marrow Transplant 25 2000 757
6. C.R. Li, P.D. Greenberg, M.J. Gilbert, J.M. Goodrich, S.R. Riddell Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant correlation with CMV disease and effect of ganciclovir prophylaxis Blood 83 1994 1971
7. M. Hakki, S.R. Riddell, J. Storek, R.A. Carter, T. Stevens-Ayers, P. Sudour, K. White, L. Corey, M. Boeckh Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation impact of host factors, drug therapy, and subclinical reactivation Blood 102 2003 3060
8. A.P. Limaye Ganciclovir-resistant cytomegalovirus in organ transplant recipients Clin Infect Dis 35 2002 866
9. T. Eckle, P. Lang, L. Prix, G. Jahn, T. Klingebiel, R. Handgretinger, B. Selle, D. Niethammer, K. Hamprecht Rapid development of ganciclovir-resistant cytomegalovirus infection in children after allogeneic stem cell transplantation in the early phase of immune cell recovery Bone Marrow Transplant 30 2002 433
10. M. Boeckh, G.M. Gallez-Hawkins, D. Myerson, J.A. Zaia, R.A. Bowden Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture Transplantation 64 1997 108
11. E.A. Walter, P.D. Greenberg, M.J. Gilbert, R.J. Finch, K.S. Watanabe, E.D. Thomas, S.R. Riddell Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor N Engl J Med 333 1995 1038
12. S.R. Riddell, K.S. Watanabe, J.M. Goodrich, C.R. Li, M.E. Agha, P.D. Greenberg Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones Science 257 1992 238
13. H. Einsele, E. Roosnek, N. Rufer, C. Sinzger, S. Riegler, J. Loffler, U. Grigoleit, A. Moris, H.G. Rammensee, L. Kanz, A. Kleihauer, F. Frank, G. Jahn, H. Hebart Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy Blood 99 2002 3916
14. K.S. Peggs, S. Verfuerth, A. Pizzey, N. Khan, M. Guiver, P.A. Moss, S. Mackinnon Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines Lancet 362 2003 1375
15. K. Cwynarski, J. Ainsworth, M. Cobbold, S. Wagner, P. Mahendra, J. Apperley, J. Goldman, C. Craddock, P.A. Moss Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation Blood 97 2001 1232
16. P. Reusser, G. Cathomas, R. Attenhofer, M. Tamm, G. Thiel Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load J Infect Dis 180 1999 247
17. A.H. Rook, G.V. Quinnan Jr, W.J. Frederick, J.F. Manischewitz, N. Kirmani, T. Dantzler, B.B. Lee, C.B. Currier Jr Importance of cytotoxic lymphocytes during cytomegalovirus infection in renal transplant recipients Am J Med 76 1984 385
18. S. Singhal, J.C. Shaw, J. Ainsworth, M. Hathaway, G.M. Gillespie, H. Paris, K. Ward, D. Pillay, P.A. Moss, D.J. Mutimer Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patients Transplantation 69 2000 2251
19. J.W. Gratama, J.W. van Esser, C.H. Lamers, C. Tournay, B. Lowenberg, R.L. Bolhuis, J.J. Cornelissen Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection Blood 98 2001 1358
20. A.F. Hassan-Walker, A.L. Vargas Cuero, F.M. Mattes, P. Klenerman, F. Lechner, A.K. Burroughs, P.D. Griffiths, R.E. Phillips, V.C. Emery CD8+ cytotoxic lymphocyte responses against cytomegalovirus after liver transplantation correlation with time from transplant to receipt of tacrolimus J Infect Dis 183 2001 835
21. G.M. Gillespie, M.R. Wills, V. Appay, C. O'Callaghan, M. Murphy, N. Smith, P. Sissons, S. Rowland-Jones, J.I. Bell, P.A. Moss Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors J Virol 74 2000 8140
22. E. Ozdemir, L.S. John St, G. Gillespie, S. Rowland-Jones, R.E. Champlin, J.J. Molldrem, K.V. Komanduri Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells Blood 100 2002 3690
23. L.E. Gamadia, E.B. Remmerswaal, J.F. Weel, F. Bemelman, R.A. van Lier, I.J. Ten Berge Primary immune responses to human CMV a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease Blood 101 2003 2686
24. M. Engstrand, A.K. Lidehall, T.H. Totterman, B. Herrman, B.M. Eriksson, O. Korsgren Cellular responses to cytomegalovirus in immunosuppressed patients circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment Clin Exp Immunol 132 2003 96
25. D.D. Anthony, P.V. Lehmann T-cell epitope mapping using the ELISPOT approach Methods 29 2003 260
26. A. Gazagne, E. Claret, J. Wijdenes, H. Yssel, F. Bousquet, E. Levy, P. Vielh, F. Scotte, T.L. Goupil, W.H. Fridman, E. Tartour A Fluorospot assay to detect single T lymphocytes simultaneously producing multiple cytokines J Immunol Methods 283 2003 91
27. W. Herr, B. Linn, N. Leister, E. Wandel, K.H. Meyer zum Buschenfelde, T. Wolfel The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens J Immunol Methods 203 1997 141
28. G. Aubert, A.F. Hassan-Walker, J.A. Madrigal, V.C. Emery, C. Morte, S. Grace, M.B. Koh, M. Potter, H.G. Prentice, I.A. Dodi, P.J. Travers Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants J Infect Dis 184 2001 955
29. L. Papagno, V. Appay, J. Sutton, T. Rostron, G.M. Gillespie, G.S. Ogg, A. King, A.T. Makadzanhge, A. Waters, C. Balotta, A. Vyakarnam, P.J. Easterbrook, S.L. Rowland-Jones Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors Clin Exp Immunol 130 2002 509
30. H. Hebart, S. Daginik, S. Stevanovic, U. Grigoleit, A. Dobler, M. Baur, G. Rauser, C. Sinzger, G. Jahn, J. Loeffler, L. Kanz, H.G. Rammensee, H. Einsele Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation Blood 99 2002 3830
31. R.D. Salter, P. Cresswell Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid Embo J 5 1986 943
32. Y. Shi, K.D. Smith, C.T. Lutz TAP-independent MHC class I peptide antigen presentation to alloreactive CTL is enhanced by target cell incubation at subphysiologic temperatures J Immunol 160 1998 4305
33. J.R. Currier, E.G. Kuta, E. Turk, L.B. Earhart, L. Loomis-Price, S. Janetzki, G. Ferrari, D.L. Birx, J.H. Cox A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays J Immunol Methods 260 2002 157
34. A.C. Karlsson, J.N. Martin, S.R. Younger, B.M. Bredt, L. Epling, R. Ronquillo, A. Varma, S.G. Deeks, J.M. McCune, D.F. Nixon, E. Sinclair Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells J Immunol Methods 283 2003 141
35. J. Banchereau, A.K. Palucka, M. Dhodapkar, S. Burkeholder, N. Taquet, A. Rolland, S. Taquet, S. Coquery, K.M. Wittkowski, N. Bhardwaj, L. Pineiro, R. Steinman, J. Fay Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine Cancer Res 61 2001 6451
36. M. Bodinier, M.A. Peyrat, C. Tournay, F. Davodeau, F. Romagne, M. Bonneville, F. Lang Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding Nat Med 6 2000 707
37. P. Champagne, G.S. Ogg, A.S. King, C. Knabenhans, K. Ellefsen, M. Nobile, V. Appay, G.P. Rizzardi, S. Fleury, M. Lipp, R. Forster, S. Rowland-Jones, R.P. Sekaly, A.J. McMichael, G. Pantaleo Skewed maturation of memory HIV-specific CD8 T lymphocytes Nature 410 2001 106
38. L.E. Gamadia, R.J. Rentenaar, P.A. Baars, E.B. Remmerswaal, S. Surachno, J.F. Weel, M. Toebes, T.N. Schumacher, I.J. ten Berge, R.A. van Lier Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers Blood 98 2001 754
39. J.T. Harty, A.R. Tvinnereim, D.W. White CD8+ T cell effector mechanisms in resistance to infection Annu Rev Immunol 18 2000 275
40. V. Cerundolo, J. Alexander, K. Anderson, C. Lamb, P. Cresswell, A. McMichael, F. Gotch, A. Townsend Presentation of viral antigen controlled by a gene in the major histocompatibility complex Nature 345 1990 449
41. W. Jennes, L. Kestens, D.F. Nixon, B.L. Shacklett Enhanced ELISPOT detection of antigen-specific T cell responses from cryopreserved specimens with addition of both IL-7 and IL-15--the Amplispot assay J Immunol Methods 270 2002 99
42. C. Scheibenbogen, P. Romero, L. Rivoltini, W. Herr, A. Schmittel, J.C. Cerottini, T. Woelfel, A.M. Eggermont, U. Keilholz Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay a four-centre comparative trial J Immunol Methods 244 2000 81
43. M.V. Dhodapkar, J.W. Young, P.B. Chapman, W.I. Cox, J.F. Fonteneau, S. Amigorena, A.N. Houghton, R.M. Steinman, N. Bhardwaj Paucity of functional T-cell memory to melanoma antigens in healthy donors and melanoma patients Clin Cancer Res 6 2000 4831
44. E. Jager, Y. Nagata, S. Gnjatic, H. Wada, E. Stockert, J. Karbach, P.R. Dunbar, S.Y. Lee, A. Jungbluth, D. Jager, M. Arand, G. Ritter, V. Cerundolo, B. Dupont, Y.T. Chen, L.J. Old, A. Knuth Monitoring CD8 T cell responses to NY-ESO-1 correlation of humoral and cellular immune responses Proc Natl Acad Sci U S A 97 2000 4760
45. C. Rentzsch, S. Kayser, S. Stumm, I. Watermann, S. Walter, S. Stevanovic, D. Wallwiener, B. Guckel Evaluation of pre-existent immunity in patients with primary breast cancer molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells Clin Cancer Res 9 2003 4376
46. B.C. Schultes, T.L. Whiteside Monitoring of immune responses to CA125 with an IFN-gamma ELISPOT assay J Immunol Methods 279 2003 1
47. M. Larsson, D. Messmer, S. Somersan, J.F. Fonteneau, S.M. Donahoe, M. Lee, P.R. Dunbar, V. Cerundolo, I. Julkunen, D.F. Nixon, N. Bhardwaj Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells J Immunol 165 2000 1182
48. J.K. Sandberg, N.M. Fast, D.F. Nixon Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes J Immunol 167 2001 181
49. W. Herr, J. Schneider, A.W. Lohse, K.H. Meyer zum Buschenfelde, T. Wolfel Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens J Immunol Methods 191 1996 131
50. F.H. Rininsland, T. Helms, R.J. Asaad, B.O. Boehm, M. Tary-Lehmann Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity J Immunol Methods 240 2000 143
51. D.G. Lim, K. Bieganowska Bourcier, G.J. Freeman, D.A. Hafler Examination of CD8+ T cell function in humans using MHC class I tetramers similar cytotoxicity but variable proliferation and cytokine production among different clonal CD8+ T cells specific to a single viral epitope J Immunol 165 2000 6214
52. M.K. Slifka, F. Rodriguez, J.L. Whitton Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells Nature 401 1999 76
53. M.F. Bachmann, M. Barner, A. Viola, M. Kopf Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection Eur J Immunol 29 1999 291
54. J.E. Snyder, W.J. Bowers, A.M. Livingstone, F.E. Lee, H.J. Federoff, T.R. Mosmann Measuring the frequency of mouse and human cytotoxic T cells by the Lysispot assay independent regulation of cytokine secretion and short-term killing Nat Med 9 2003 231
55. U. Keilholz, J. Weber, J.H. Finke, D.I. Gabrilovich, W.M. Kast, M.L. Disis, J.M. Kirkwood, C. Scheibenbogen, J. Schlom, V.C. Maino, H.K. Lyerly, P.P. Lee, W. Storkus, F. Marincola, A. Worobec, M.B. Atkins Immunologic monitoring of cancer vaccine therapy results of a workshop sponsored by the Society for Biological Therapy J Immunother 25 2002 97
56. J.J. Lewis, S. Janetzki, S. Schaed, K.S. Panageas, S. Wang, L. Williams, M. Meyers, L. Butterworth, P.O. Livingston, P.B. Chapman, A.N. Houghton Evaluation of CD8(+) T- cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide Int J Cancer 87 2000 391
57. N. Khan, M. Cobbold, R. Keenan, P.A. Moss Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype J Infect Dis 185 2002 1025
58. F. Kern, N. Faulhaber, C. Frommel, E. Khatamzas, S. Prosch, C. Schonemann, I. Kretzschmar, R. Volkmer-Engert, H.D. Volk, P. Reinke Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides Eur J Immunol 30 2000 1676
59. Z. Gyulai, V. Endresz, K. Burian, S. Pincus, J. Toldy, W.I. Cox, C. Meric, S. Plotkin, E. Gonczol, K. Berencsi Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals reevaluation of prevalence of IE1-specific CTLs J Infect Dis 181 2000 1537
60. R. Elkington, S. Walker, T. Crough, M. Menzies, J. Tellam, M. Bharadwaj, R. Khanna Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers J Virol 77 2003 5226
61. M.R. Wills, A.J. Carmichael, K. Mynard, X. Jin, M.P. Weekes, B. Plachter, J.G. Sissons The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65 frequency, specificity, and T-cell receptor usage of pp65-specific CTL J Virol 70 1996 7569
62. A. Solache, C.L. Morgan, A.I. Dodi, C. Morte, I. Scott, C. Baboonian, B. Zal, J. Goldman, J.E. Grundy, J.A. Madrigal Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus J Immunol 163 1999 5512
63. J. Longmate, J. York, C. La Rosa, R. Krishnan, M. Zhang, D. Senitzer, D.J. Diamond Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes Immunogenetics 52 2001 165